Jump to main content

yr 〜
yr

Search results 33

Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT)

Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT)
Digital博士論文障害者向け資料あり
中野, 暖2022-03-31
National Diet Library
  • Subject HeadingSGLT2 omics analysis canagliflozin ...

Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice 27 11

Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice 27 11
Digital博士論文障害者向け資料あり
Rahadian, Arief, Fukuda, Daiju, Salim, Hotimah Masdan, Yagi, Shusuke, Kusunose, Kenya, Yamada, Hirotsugu, Soeki, Takeshi, Sata, MasatakaJapan Atherosclerosis Society2020-11-01Journal of Atherosclerosis and Thrombosis
National Diet Library
  • Subject HeadingSGLT2 inhibitor Canagliflozin Ather...
  • Note (General)... 2 inhibitors (SGLT2is) reduce card......agliflozin, an SGLT2i, on atherogenesis and invest...

Beneficial effects of SGLT2 inhibitor on metabolic inflexibility and visceral fat amount in an animal model of obese type 2 diabetes

Beneficial effects of SGLT2 inhibitor on metabolic inflexibility and visceral fat amount in an animal model of obese type 2 diabetes
Digital博士論文障害者向け資料あり
原, 健人2023-07-01
National Diet Library
  • Subject HeadingFat oxidation Metabolic inflexibility Obesity SGLT2 inhibitor Type 2 diabetes mel...
  • Alternative Title肥満2型糖尿病の動物モデルにおけるSGLT2阻害剤のエネルギー代謝リズムと内臓脂肪量に対する有益な効果
  • Alternative Title肥満2型糖尿病の動物モデルにおけるSGLT2阻害剤のエネルギー代謝リズムと内臓脂肪量に対する有益な効果

Effects of a Novel Selective PPARα Modulator, Statin, Sodium-Glucose Cotransporter 2 Inhibitor, and Combinatorial Therapy on the Liver and Vasculature of Medaka Nonalcoholic Steatohepatitis Model

Effects of a Novel Selective PPARα Modulator, Statin, Sodium-Glucose Cotransporter 2 Inhibitor, and Combinatorial Therapy on the Liver and Vasculature of Medaka Nonalcoholic Steatohepatitis Model
Digital博士論文障害者向け資料あり
Kimura, Atsushi2022-03-23
National Diet Library
  • Subject HeadingNASH fli::GFP transgenic medaka SPPARMα statin SGLT2 inhibitor

Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 Inhibitor use

Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 Inhibitor use
Digital博士論文障害者向け資料あり
後藤, 由佳2021-07-01
National Diet Library
  • Subject HeadingSGLT2 inhibitor diabetes mellitus g...
  • Alternative TitleSGLT2阻害薬による骨格筋のインスリン感受性改善作用：グルコースクラ...
  • Alternative TitleSGLT2阻害薬による骨格筋のインスリン感受性改善作用：グルコースクラ...

Liver autophagy-induced valine and leucine in plasma reflect the metabolic effect of sodium glucose co-transporter 2 inhibitor dapagliflozin

Liver autophagy-induced valine and leucine in plasma reflect the metabolic effect of sodium glucose co-transporter 2 inhibitor dapagliflozin
Digital博士論文障害者向け資料あり
Furuya, Futoshi2023-05-23
Available onlineNational Diet LibraryOther Libraries in Japan
  • Subject Heading...transporter 2 (SGLT2) inhibitor Diabetes Liver Aut...
  • Alternative Title肝オートファジー誘導性の血漿中バリンおよびロイシンはSGLT2阻害薬ダパグリフロジンの代謝効果を反映する
  • Alternative Title肝オートファジー誘導性の血漿中バリンおよびロイシンはSGLT2阻害薬ダパグリフロジンの代謝効果を反映する

Inhibition of sodium glucose cotransporter 2 (SGLT2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (NASH)

Inhibition of sodium glucose cotransporter 2 (SGLT2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (NASH)
Digital博士論文障害者向け資料あり
Goto, Ryo2019-09-20
National Diet Library
  • Subject Headingd-rR/Tokyo medaka liver fibrosis NASH SGLT2 tofogliflozin
  • Note (General)...transporter 2 (SGLT2) inhibitors, h......e effect of an SGLT2 inhibitor on t...... effect of the SGLT2 inhibitor, tof......port here that SGLT2 is expressed in medaka fish a...
  • Alternative TitleSGLT2阻害薬はメダカNASHモデルにおいて肝の線維化を遅らせた

SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition. 32 3

SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition. 32 3
Digital博士論文障害者向け資料あり
富田, 一聖, TOMITA, IsseiElsevier B.V.2020Cell metabolism
National Diet Library
  • Subject Heading...is ketone body SGLT2 inhibitor lipolysis ketolysis...
  • Note (General)pdf SGLT2 inhibitors off......ings show that SGLT2 inhibition-associated renopro...

Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes

Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes
Digital博士論文
吉本, 卓生2017-09-27
National Diet Library
  • Subject HeadingSGLT2 inhibitor blood pressure type...
  • Note (General)...transporter 2 (SGLT2) inhibitors on......2 diabetes. An SGLT2 inhibitor (can......Treatment with SGLT2 inhibitors sig......inistration of SGLT2 inhibitors. Ho......treatment with SGLT2 inhibitors does not activate ...

Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity

Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity
Digital博士論文障害者向け資料あり
岡田, 純一群馬大学医学系研究科2020-09-30
National Diet Library
  • Subject Headingダパグリフロジン SGLT2　阻害薬 癌 drug repositioning 細胞接着...

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study). 10

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study). 10
Digital博士論文障害者向け資料あり
Nakajima, Hiroki, Okada, Sadanori, Mohri, Takako, Kanda, Eiichiro, Inaba, Naoyuki, Hirasawa, Yoko, Seino, Hiroaki, Kuroda, Hisamoto, Hiyoshi, Toru, Niiya, Tetsuji, Ishii, HitoshiBioMed Central2018-03-01Diabetology and metabolic syndrome
National Diet Library
  • Subject Heading...s 2 inhibitors SGLT2 inhibitors Dapagliflozin Trea...
  • Note (General)...ransporters 2 (SGLT2) inhibitors in......agliflozin, an SGLT2 inhibitor, improves treatment...

Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice

Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice
Digital博士論文
ラハディアン, アリエフ, 福田, 大受, Salim, Hotimah Masdan, 八木, 秀介, 楠瀬, 賢也, 山田, 博胤, 添木, 武, 佐田, 政隆Japan Atherosclerosis Society2020-11-01Journal of Atherosclerosis and Thrombosis27 11p.1141-1151
Available onlineOther Libraries in Japan
  • Summary, etc.... 2 inhibitors (SGLT2is) reduce card......agliflozin, an SGLT2i, on atherogenesis and invest...
  • Subject HeadingSGLT2 inhibitor Canagliflozin Ather...

当院におけるSGLT2阻害剤の使用状況

当院におけるSGLT2阻害剤の使用状況
Digital文書・図像類
宅江, 孝修, 吉田, 勝好, 田原, 明子, 郷原, 学, 又賀, 建太郎日本赤十字社医学会2016-09-01日赤医学68 1p.212-212
Other Libraries in Japan
  • Subject HeadingSGLT2阻害剤 SGLT2 糖尿病

ダパグリフロジンの有効性と腎機能の関連についての検討

ダパグリフロジンの有効性と腎機能の関連についての検討
Digital文書・図像類
石橋, 楽至, 倉井, 由香, 柿沼, 博子, 高野, 尊行, 中丸, 朗日本赤十字社医学会2018-09-01日赤医学70 1p.277-277
Other Libraries in Japan
  • Subject Heading糖尿病 SGLT2阻害薬 腎機能

イプラグリフロジンの有効性と腎機能への影響

イプラグリフロジンの有効性と腎機能への影響
Digital文書・図像類
小杉, 稔, 若本, 瑞穂, 伊藤, 宏彰日本赤十字社医学会2019-09-01日赤医学71 1p.281-281
Other Libraries in Japan
  • Subject HeadingSGLT２阻害薬 イプラグリフロジン 腎機能低下

マスイメージングによる腎代謝産物の解析に基づくSGLT2阻害薬の腎保護効果の解明

マスイメージングによる腎代謝産物の解析に基づくSGLT2阻害薬の腎保護効果の解明
Digital文書・図像類
萩原, あいか, 宮下, 和季, 伊藤, 裕2019科学研究費補助金研究成果報告書
Other Libraries in Japan
  • Subject HeadingSGLT2阻害薬,アデニル酸代謝,腎保護効果
  • Note (General)...産物の可視化解析を行った結果、SGLT2阻害薬による尿糖増加に伴う腎糖......c effect of an SGLT2 inhibitor in obese mice. The ...
  • Alternative Title... ノ カイセキ ニ モトズク SGLT2 ソガイヤク ノ ジン ホゴ ......ki ni motozuku SGLT2 sogaiyaku no j...... effects of an SGLT2 inhibitor through analysis of...

SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition.

SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition.
Digital博士論文
富田, 一聖, TOMITA, IsseiElsevier B.V.2020Cell metabolism32 3p.404-419.e6
Available onlineOther Libraries in Japan
  • Summary, etc.SGLT2 inhibitors off......ings show that SGLT2 inhibition-associated renopro...
  • Subject Heading...is ketone body SGLT2 inhibitor lipolysis ketolysis...

Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity

Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity
Digital博士論文
岡田, 純一群馬大学医学系研究科2020-09-30
Available onlineOther Libraries in Japan
  • Subject Headingダパグリフロジン SGLT2　阻害薬 癌 drug repositioning 細胞接着...

SGLT2阻害薬を開始する際にチアゾリジンは必要か？

SGLT2阻害薬を開始する際にチアゾリジンは必要か？
Digital文書・図像類
伊藤, 俊, 高佐, 顕之, 上田, 研, 渡久山, 哲男, 中川, 潤一日本赤十字社医学会2016-09-01日赤医学68 1p.128-128
Other Libraries in Japan
  • Subject HeadingSGLT2阻害薬 チアゾリジン 併用

SGLT2阻害薬内服るい痩高齢者の糖尿病ケトアシドーシスの1例

SGLT2阻害薬内服るい痩高齢者の糖尿病ケトアシドーシスの1例
Digital文書・図像類
小黒, 希理, 後藤, 尚, 工藤, 宏仁, 清水, 尚子, 小山, 昌平, 岩村, 庄吾, 小松田, 智也, 山中, 有美子日本赤十字社医学会2017-09-01日赤医学69 1p.222-222
Other Libraries in Japan
  • Subject HeadingSGLT2阻害薬 糖尿病 糖尿病ケトアシドーシス
RSS